Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $234.67 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $87.94 | 5 | $0 (2018) |
| Medtronic, Inc. | $80.74 | 2 | $0 (2024) |
| Lilly USA, LLC | $25.64 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $20.54 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $19.81 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.74 | 2 | Medtronic, Inc. ($80.74) |
| 2022 | $25.64 | 1 | Lilly USA, LLC ($25.64) |
| 2020 | $20.54 | 1 | Neurocrine Biosciences, Inc. ($20.54) |
| 2018 | $53.97 | 3 | GlaxoSmithKline, LLC. ($34.16) |
| 2017 | $53.78 | 3 | GlaxoSmithKline, LLC. ($53.78) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $52.19 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/26/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Neuroscience | ||||||
| 03/11/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NEUROLOGY | ||||||
| 04/17/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: VACCINES | ||||||
| 02/23/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 02/12/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: VACCINES | ||||||
| 11/21/2017 | GlaxoSmithKline, LLC. | MENVEO (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: VACCINES | ||||||
| 09/18/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 227 | 886 | $158,608 | $42,200 |
| 2022 | 4 | 213 | 979 | $174,555 | $47,625 |
| 2021 | 13 | 1,236 | 1,928 | $207,660 | $77,824 |
| 2020 | 4 | 251 | 675 | $113,686 | $29,066 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 622 | $123,156 | $29,397 | 23.9% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 33 | 169 | $20,280 | $8,093 | 39.9% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 17 | 17 | $6,599 | $1,752 | 26.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $2,330 | $1,553 | 66.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 38 | $6,042 | $1,213 | 20.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 28 | $200.64 | $192.99 | 96.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 868 | $164,633 | $44,198 | 26.8% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 27 | 54 | $6,480 | $2,885 | 44.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 22 | $3,232 | $437.28 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 35 | $210.00 | $104.22 | 49.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 159 | 778 | $139,289 | $45,154 | 32.4% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 291 | 293 | $16,330 | $12,443 | 76.2% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 280 | 284 | $13,480 | $8,924 | 66.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 58 | 70 | $10,165 | $2,614 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 22 | $5,660 | $2,150 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $4,208 | $1,906 | 45.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 73 | 73 | $2,308 | $1,529 | 66.2% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 40 | 40 | $1,875 | $1,425 | 76.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 17 | 17 | $3,315 | $977.70 | 29.5% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 11 | 11 | $660.00 | $495.99 | 75.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 50 | 68 | $408.00 | $204.00 | 50.0% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 180 | 208 | $9,361 | $2.08 | 0.0% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 44 | 51 | $600.41 | $0.51 | 0.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 183 | 602 | $105,558 | $26,594 | 25.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 24 | 24 | $4,915 | $1,859 | 37.8% |
About Dr. Daryoush Kashani, M.D
Dr. Daryoush Kashani, M.D is a Family Medicine healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386847531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daryoush Kashani, M.D has received a total of $234.67 in payments from pharmaceutical and medical device companies, with $80.74 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($234.67).
As a Medicare-enrolled provider, Kashani has provided services to 1,927 Medicare beneficiaries, totaling 4,468 services with total Medicare billing of $196,715. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Panorama City, CA
- Active Since 06/06/2007
- Last Updated 02/14/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386847531
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $80.74
- BEXSERO (Biological) $47.65
- EMGALITY (Drug) $25.64
- ADVAIR (Drug) $22.02
- INGREZZA (Drug) $20.54
- TOUJEO (Drug) $19.81
- MENVEO (Biological) $18.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Panorama City
Mrs. Shovek Boyadjian
Family Medicine — Payments: $11,818
Reyadh Michail, M.d, M.D
Family Medicine — Payments: $9,576
Jose Elacion, M.d, M.D
Family Medicine — Payments: $1,953
Nana Barseghian, Md, MD
Family Medicine — Payments: $1,617
Heidi Pang, Do, DO
Family Medicine — Payments: $1,230
Dr. Arash Karimi Afshar, Do, DO
Family Medicine — Payments: $744.10